Jorge Leon, Kimberly Popovits, David Stone, David Singer, Andrew MacDonald, David Persing, Stuart Lacock, Daniel Hartman, David Hermann, Peter Van Ess, Jun-Jei Sheu, Rob Hutchison, Takara Bio, Bayer HealthCare | GenomeWeb

Pairings

Jorge Leon has been appointed acting chief scientific officer and vice president of business development of Orion Genomics, the St. Louis-based company said last week. In addition, he has joined the company's board of directors. Leon is president of Leomics Associates, a company he founded. Prior to that, he held different positions at Quest Diagnostics. Leon holds a PhD in cellular and molecular biology from New York University.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.